Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of soothing and cooling after Gaviscon products versus control in post-meal heartburn
2008-006413-25Phase 4Completed
- Sponsor
- Reckitt
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Gaviscon Double Action in gastroesophageal reflux disease (GERD) (4 arms), sponsored by Reckitt. Primary endpoints: Time to first perceived soothing effect and Time to first perceived cooling effect. Started Jan 2009; status: completed.
02
Drugs
Gaviscon Double Action
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2008-006413-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006413-25.